نشر يوم 14. July 2015

Cancer immunotherapy center opened at Vivantes Spandau Hospital

A cancer immunotherapy center has now been established at Vivantes Spandau Hospital. Here, oncologists, dermatologists, gastroenterologists and pulmonologists work together on an interdisciplinary basis.

The aim of cancer immunotherapy is to mobilize the patient's own immune system to fight his tumor disease. The so-called immune checkpoint inhibitors (PD-1, PD-L-1 and CTLA-4 inhibitors) can be used to support the body's own immune system in fighting cancer. Recently, the first PD-1 antibody was approved for Germany, initially for the treatment of black skin cancer (malignant melanoma), and since a week ago also for a certain form of lung cancer. The first patients with these diseases have already been treated accordingly at the Cancer Immunotherapy Center at Spandau Hospital. Several patients with lung cancer have been treated for some time with PD-1 and PD-L-1 antibodies as part of studies.

Treatment with immune checkpoint inhibitors requires special expertise, since in individual cases severe immunological side effects can occur as a result of this treatment. For this reason, various specialists from the departments of oncology, dermatology, gastroenterology and pneumology as well as specialized nursing staff work together at Vivantes Spandau Hospital to provide professional care during treatment with immune checkpoint inhibitors. The new cancer immunotherapy center is headed by Prof. Dr. Späth-Schwalbe (cancer specialist) in collaboration with Prof. Dr. Harth and Dr. Henschel (skin cancer specialists).

The approval of immune checkpoint inhibitors for other cancers is expected later this year or in the course of next year.

Vivantes awarded by German Society for Thoracic Surgery!
Excellent Center for Thoracic Surgery
View event
Why Me?
View event
Stressed skin
View event
Gastroenterology at Vivantes Humboldt Hospital under new management
PD Dr. Tobias J. Weismüller becomes head of the clinic
View event
E-cigarette – way out or dead end?
View event
First Cancer Center recognized at Vivantes: When several organs are affected by cancer
Cancer Center Berlin-Neukölln certified by German Cancer Society
View event
Vivantes Neukölln Hospital opens state-of-the-art computed tomography center
More efficient diagnostics also for COVID-19 patients
View event
Science & Education: Corona
View event
Visceral Oncology Center certified by German Cancer Society
Center for stomach cancer, pancreatic cancer and colorectal cancer at Vivantes Neukölln Hospital approved
View event
Application of the cooling cap for hair preservation during chemotherapy
Head skin cooling during chemotherapy
View event
Comprehensive treatment of skin cancer
View event
Center at Vivantes Auguste-Viktoria Hospital receives award
German Cancer Society certifies interdisciplinary colorectal cancer center in Schöneberg
View event
Skin cancer – what is visible from here
View event
Power Carrier
View event
Good for the liver
View event
What does the MEDICAL BOARD do?
View event
The undetected
There are diseases that only become known because a celebrity is affected by them. One example is oral cavity carcinoma, which recently claimed the life of the well-known actor Jan Fedder. If it is discovered at an early stage, it is usually curable.
View event
Dangerous tinies
View event
Tumor conferences
Experts from different disciplines decide together
View event
The underestimated danger
View event
Vivantes Center for Nutritional Medicine under new management
Prof. Dr. Diana Rubin heads the interdisciplinary facility in the north of Berlin.
View event